Several immunization studies with attenuated typhoid vaccine candidates suggested that cell-mediated immunity (CMI), particularly CD8+ effector T cells, constitute a major component in the control of typhoid fever [10, 11]. The gene discussed is CD8A; the disease is typhoid fever.